Aurobindo Pharma Ltd said on Thursday it would make and sell U.S.-based COVAXX's COVID-19 vaccine candidate for supply in India and to the United Nations Children's Fund (UNICEF) under a licensing deal. Shares of Aurobindo Pharma rose as much as 2.3% and were trading up 1.4% as of 0403 GMT in an upbeat Mumbai market. Its licensing deal comes as COVID-19 infections in India continue to rise after crossing 10 million last week. India, the world's biggest vaccine producing country, is also considering emergency use authorization applications for vaccines made by Pfizer and local company Bharat Biotech. Last month, COVAXX said it had received purchase commitments totaling $2.8 billion to deliver more than 140 million doses of its potential COVID-19 vaccine to developing countries, including Brazil, Peru and Ecuador.

Source: Mint December 24, 2020 05:38 UTC